SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, whose advanced TriGrid electroporation system is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today that recruitment of patients has commenced for the final and highest dose level for their Phase I melanoma vaccine clinical trial in the study being conducted by Memorial Sloan-Kettering Cancer Center.
